Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs XLRE✓SelectedUSD · XLREGSK vs XLRE performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs XLRE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.6%
XLRE return
-0.2%
Excess return
-4.4%
Maximum drawdown
-13.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioXLREExcessAlpha
1D-1.6%-1.7%+0.1%-0.1%
7D-4.7%-3.3%-1.4%-1.9%
30D-4.7%+1.2%-5.9%-5.3%
3M-8.8%-3.9%-4.9%-5.3%
6M-4.6%-0.7%-3.9%-3.5%
All-4.6%-0.2%-4.4%-3.5%

Cumulative growth

Daily Returns

Daily percentage return beside XLRE.

Daily Out/Under-Performance

Portfolio return minus XLRE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × XLRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded XLRE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling